Moreover, even in cancer like GISTs driven by other kinases, activation of KIT or PDGFR-α lead to phosphorylation of ERK 1/2 [25] and these kinases mediate the proliferative advantage of the neoplastic cells. The gene discussed is KIT; the disease is cancer.